Table 3.
Early implant discontinuation and duration of use by implant type among study participants.
| Implant type | Early discontinuation | Total | Duration of use (Yes only) |
|
|---|---|---|---|---|
| No n (%) | Yes n (%) | n | n (%) | |
| Implanon | 427 (70.5) | 179 (29.5) | 606 | 1–6 Months: 37 (20.7) 7–12 Months: 66 (36.8) 13–18 Months: 52 (29.1) 19–24 Months: 24 (13.4) |
| Jadelle | 199 (74.3) | 69 (25.7) | 268 | 1–6 Months: 14 (20.3) 7–12 Months: 23 (33.3) 13–18 Months: 18 (26.1) 19–24 Months: 14 (20.3) |
| Total | 626 (71.6) | 248 (28.4) | 874 | 1–6 Months: 51 (20.6) 7–12 Months: 89 (35.9) 13–18 Months: 70 (28.2) 19–24 Months: 38 (15.3) |